HopeStage
Back to all studies
CompletedNCT00012558

Long-term treatment options for people with bipolarity

About this titleRead the official source — NCT00012558
Medication studyAges 15+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 15 years.

Listed locations
Stanford and 10 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 1998
Recruitment status
Completed
Enrollment listed in the registry
5,000
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Behavioural, Drug
Locations
United States
Age range
Over 15 Years
Official registry ID
NCT00012558
Official title
Show the full official title

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Stanford · Denver · Boston

8 more locations
  • Worcester
  • Cleveland
  • Tulsa
  • Portland
  • Philadelphia
  • Pittsburgh
  • Houston
  • San Antonio

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including lithium, valproate, bupropion, paroxetine, lamotrigine, risperidone, inositol and tranylcypromine.

Who was this study for?

Listed age limits: from 15 years.

Want to explore more studies?

Explore studies